Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 63OTHER_GOV 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Locally Advanced Cervical Cancer 1Colonic Neoplasms 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Curcumin × Clear all
NCT06080841 2025-05-25

Curcumin Supplementation in Cervical Cancer

National Institute of Cancerología

Phase NA Recruiting
30 enrolled
Gynecologic

Locally Advanced Cervical Cancer

NCT04294836 2022-12-07

Curcumin in Advanced Cervical Cancer

Instituto Nacional de Cancerologia, Columbia

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT00486460 2007-06-14

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00295035 2006-02-22

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
100 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡